title: Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency.
abstract: Reactivation of cytomegalovirus (CMV) from latency is a frequent complication of organ transplantation, and the molecular mechanism by which this occurs is unknown. Previous studies have shown that allogeneic stimulation induces reactivation of human CMV (HCMV) in vitro (64). We find that transplantation of vascularized allogeneic kidneys induces murine CMV (MCMV) and HCMV immediate-early (ie) gene expression. This induction is accompanied by increased expression of transcripts encoding inflammatory cytokines, including tumor necrosis factor (TNF), interleukin-2, and gamma interferon, and by activation of NF-kappaB. TNF alone can substitute for allogeneic transplantation in inducing HCMV and MCMV ie gene expression in some tissues. Our studies suggest that reactivation is a multistep process which is initiated by factors that induce ie gene expression, including TNF and NF-kappaB. Allogeneic transplantation combined with immunosuppression may be required to achieve complete reactivation in vivo.
authors: Department of Surgery, Division of Organ Transplantation, Northwestern University Medical School, Chicago, Illinois 60611, USA.
authors: M
authors: M
authors: Hummel
authors: Z
authors: Z
authors: Zhang
authors: S
authors: S
authors: Yan
authors: I
authors: I
authors: DePlaen
authors: P
authors: P
authors: Golia
authors: T
authors: T
authors: Varghese
authors: G
authors: G
authors: Thomas
authors: M I
authors: MI
authors: Abecassis
mesh_terms: D000818:Animals; D016207:Cytokines / Q000235:genetics; D003587:Cytomegalovirus / Q000235:genetics / Q000254:growth & development*; D005260:Female; D015870:Gene Expression; D005814:Genes, Viral; D006801:Humans; D017874:Immediate-Early Proteins / Q000235:genetics*; D016030:Kidney Transplantation; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008954:Models, Biological; D018146:Muromegalovirus / Q000235:genetics / Q000254:growth & development*; D016328:NF-kappa B / Q000378:metabolism; D015534:Trans-Activators / Q000235:genetics*; D014184:Transplantation, Homologous; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics / Q000378:metabolism; D014764:Viral Proteins; D014775:Virus Activation; D017735:Virus Latency
chemical_list: D016207:Cytokines; C094775:IE-1 protein, murine cytomegalovirus; C088645:IE1 protein, cytomegalovirus; D017874:Immediate-Early Proteins; D016328:NF-kappa B; D015534:Trans-Activators; D014409:Tumor Necrosis Factor-alpha; D014764:Viral Proteins